We also assessed whether the anti-tumor activity of the CD26 mAb, 1F7, against T-cell leukemia/lymphoma cells, correlated with the translocation of CD26 into nucleus of human tumor cells. This evidence concerns the gene DPP4 and T-cell leukemia.